Denis Chem Lab Ltd

VS Holding B V has sold 1.50% of its shareholding in Denis Chem Lab Limited. The transaction involved the sale of 1,999,888 shares, reducing its holding from 16.46% to 14.41%. The sale occurred through multiple transactions during September and October 2026. The total equity share capital of the company is Rs. 1,38,76,6680/- comprising 1,38,76,668 Equity Shares of Rs.10/- each.

Denis Chem Lab Ltd announced the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026, to July 31, 2029. The approval was granted by shareholders at the Annual General Meeting held on September 25, 2026. Dr. Patel, with extensive experience in the medical and pharmaceuticals field, is not debarred from holding directorships. The company also disclosed relationships between directors, including Dr. Himanshu C. Patel, Ms. Anar H. Patel, and Mr. Dinesh B. Patel.

Denis Chem Lab Ltd announced the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026, to July 31, 2029. The approval was granted by shareholders at the Annual General Meeting held on September 25, 2026. Dr. Patel, who holds B.E., M.S., and Ph.D. degrees, brings over seven decades of experience in the medical and pharmaceuticals field. The company confirmed that Dr. Patel is not debarred from holding a directorial position by any SEBI order or other authority. This re-appointment is in compliance with SEBI (LODR) Regulations, 2015. Dr. Patel is related to Ms. Anar H. Patel and Mr. Dinesh B. Patel.

Denis Chem Lab Ltd announced at its 45th Annual General Meeting (AGM) held on September 25, 2026, the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors. The firm will conduct secretarial audits for a term of five consecutive years, from FY 2026-27 to FY 2030-31. The appointment was confirmed by shareholders during the AGM. M/s. Kashyap R. Mehta & Partners is a firm based in Ahmedabad providing legal and advisory services in corporate laws, capital markets, and corporate governance.

Denis Chem Lab Ltd conducted its 45th Annual General Meeting (AGM) on September 25, 2026, via Video Conferencing. Key agenda items included the adoption of audited financial statements for FY26, declaration of a dividend of Rs. 2.50 per equity share, re-appointment of a director, approval of cost auditor remuneration, appointment of secretarial auditors for five years, and re-appointment of Dr. Himanshu Patel as Managing Director. The company also informed shareholders about its general progress and business performance during FY26, with no qualifications reported by auditors. E-voting results are expected within two working days.

VS Holdings BV has filed a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, with the BSE. The filing details the sale of 2,284,335 equity shares, representing 16.46% of the total voting capital, in Denis Chem Lab Limited. The transactions occurred through open market purchases over July, August, and September 2026. The total diluted share capital of Denis Chem Lab Limited remains unchanged at Rs. 1,38,76,6680/- comprising 1,38,76,668 equity shares of Rs. 10/- each.

Denis Chem Lab Ltd has filed its Annual Report for the Financial Year 2025-26 along with the Notice of its 45th Annual General Meeting (AGM). This filing, made as per SEBI (LODR) Regulations, includes the company's financial statements, directors' report, corporate governance report, and auditor's reports. The report highlights the company's vision to be a leading pharmaceutical company and its mission to deliver high-quality medical products while ensuring shareholder returns through innovation. The company is also promoting paperless compliance and encourages members to register their email addresses for receiving documents electronically.

Denis Chem Lab Ltd has filed the Notice of its 45th Annual General Meeting (AGM) along with the Annual Report for the financial year 2025-26. This submission is in compliance with SEBI (LODR) Regulations, 2015. The Annual Report details the company's performance, vision, mission, board of directors, management team, and financial statements including the Balance Sheet, Profit & Loss, and Cash Flow Statement. The company also highlighted its commitment to a 'Green Initiative' by encouraging paperless compliances and requesting members to register their email addresses for receiving documents electronically.

Denis Chem Lab Ltd has issued a notice for its 45th Annual General Meeting (AGM) along with the Annual Report for the fiscal year 2025-26. This filing, made pursuant to SEBI (LODR) Regulations, 2015, includes the formal notice for the AGM and the comprehensive annual report detailing the company's performance and operations. The report highlights the company's vision to be a leading pharmaceutical entity and its mission to deliver high-quality medical products while ensuring shareholder returns through innovation. Key personnel, including the Board of Directors and Management Team, are listed, along with statutory auditors, secretarial auditors, cost auditors, bankers, and the registrar & transfer agents. The company also encourages members to adopt paperless compliance by registering their email addresses.

Denis Chem Lab Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors took on record the financial results during their meeting. The company also enclosed the Limited Review Report along with the results as per SEBI (LODR) Regulations, 2015. The meeting commenced at 10:00 a.m. and concluded at 1:40 p.m.